资讯

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
The US Food and Drug Administration (FDA) has approved a medicine that would reduce the risk of acquiring HIV in adult ...
The Department of Health-Center for Health Development (DOH-CHD) Caraga introduced the ABCDE to prevent the transmission of ...
While joining Gilead Sciences in welcoming the FDA's approval of a twice-yearly shot to prevent HIV, public health advocates ...
The Food and Drug Administration on Wednesday granted approval for Gilead Sciences’ twice-yearly injectable HIV prevention ...
The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...
Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® ...
FORT LAUDERDALE, FL – Holy Cross Health has received a three-year grant from ViiV Positive Action Network to develop a ...
This isn't just portfolio trimming it's Masayoshi Son playing long ball in AI. The SoftBank founder is reportedly eyeing up ...
The story of the AIDS movement is one of regular people: students, bartenders, stay-at-home mothers, teachers, retired lawyers, immigrants, Catholic nuns, newly out gay men who had just arrived in New ...